125 related articles for article (PubMed ID: 1506868)
1. Quantitative EEG mapping and PET in Alzheimer's disease.
Szelies B; Grond M; Herholz K; Kessler J; Wullen T; Heiss WD
J Neurol Sci; 1992 Jul; 110(1-2):46-56. PubMed ID: 1506868
[TBL] [Abstract][Full Text] [Related]
2. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
Szelies B; Mielke R; Herholz K; Heiss WD
Electroencephalogr Clin Neurophysiol; 1994 Aug; 91(2):131-9. PubMed ID: 7519142
[TBL] [Abstract][Full Text] [Related]
3. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
Haense C; Buerger K; Kalbe E; Drzezga A; Teipel SJ; Markiewicz P; Herholz K; Heiss WD; Hampel H
Eur J Neurol; 2008 Nov; 15(11):1155-62. PubMed ID: 18803648
[TBL] [Abstract][Full Text] [Related]
4. Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type.
Buchan RJ; Nagata K; Yokoyama E; Langman P; Yuya H; Hirata Y; Hatazawa J; Kanno I
Electroencephalogr Clin Neurophysiol; 1997 Sep; 103(3):409-17. PubMed ID: 9305290
[TBL] [Abstract][Full Text] [Related]
5. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
Kessler J; Herholz K; Grond M; Heiss WD
Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of SPECT and quantified EEG features in Alzheimer's type dementia].
Gueguen B; Ancri D; Derouesné C; Bourdel MC; Guillou S; Landre E
Neurophysiol Clin; 1991 Dec; 21(5-6):377-87. PubMed ID: 1808497
[TBL] [Abstract][Full Text] [Related]
7. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
[TBL] [Abstract][Full Text] [Related]
8. Correlation between disease severity and brain electric LORETA tomography in Alzheimer's disease.
Gianotti LR; Künig G; Lehmann D; Faber PL; Pascual-Marqui RD; Kochi K; Schreiter-Gasser U
Clin Neurophysiol; 2007 Jan; 118(1):186-96. PubMed ID: 17070733
[TBL] [Abstract][Full Text] [Related]
9. FDG PET imaging in patients with pathologically verified dementia.
Hoffman JM; Welsh-Bohmer KA; Hanson M; Crain B; Hulette C; Earl N; Coleman RE
J Nucl Med; 2000 Nov; 41(11):1920-8. PubMed ID: 11079505
[TBL] [Abstract][Full Text] [Related]
10. Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Castellano CA; Nugent S; Paquet N; Tremblay S; Bocti C; Lacombe G; Imbeault H; Turcotte É; Fulop T; Cunnane SC
J Alzheimers Dis; 2015; 43(4):1343-53. PubMed ID: 25147107
[TBL] [Abstract][Full Text] [Related]
11. FDG PET and differential diagnosis of dementia.
Herholz K
Alzheimer Dis Assoc Disord; 1995; 9(1):6-16. PubMed ID: 7605624
[TBL] [Abstract][Full Text] [Related]
12. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Heiss WD; Szelies B; Kessler J; Herholz K
Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
[TBL] [Abstract][Full Text] [Related]
15. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
16. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
[TBL] [Abstract][Full Text] [Related]
17. [Volumetric brain changes and quantitative EEG in normal aging and Alzheimer's dementia].
Förstl H; Besthorn C; Sattel H; Zerfass R; Geiger-Kabisch C; Schreiter-Gasser U; Hentschel F
Nervenarzt; 1996 Jan; 67(1):53-61. PubMed ID: 8676989
[TBL] [Abstract][Full Text] [Related]
18. EEG power changes are related to regional cerebral glucose metabolism in vascular dementia.
Szelies B; Mielke R; Kessler J; Heiss WD
Clin Neurophysiol; 1999 Apr; 110(4):615-20. PubMed ID: 10378729
[TBL] [Abstract][Full Text] [Related]
19. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.
Ibáñez V; Pietrini P; Alexander GE; Furey ML; Teichberg D; Rajapakse JC; Rapoport SI; Schapiro MB; Horwitz B
Neurology; 1998 Jun; 50(6):1585-93. PubMed ID: 9633698
[TBL] [Abstract][Full Text] [Related]
20. Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio.
Moretti DV; Pievani M; Pini L; Guerra UP; Paghera B; Frisoni GB
Neurobiol Aging; 2017 Oct; 58():213-224. PubMed ID: 28755648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
